Intas Pharmaceuticals Limited Glimepiride Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Glimepiride Export Records India — #15 Exporter, 40 Shipments, $508.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Glimepiride

India Pharmaceutical Trade Intelligence

$76.3M242 Suppliers94 CountriesHS 30049099

ExportsIndia → UNITED STATES67.1%India → SOUTH AFRICA4.8%

ImportsMALTA → India$43.6K GREECE → India$5.3K

#1 Supplier: INDOCO REMEDIES #1 Buyer: EVERSANA LIFE

Intas Pharmaceuticals Limited — Glimepiride Exporter #15 | $508.7K Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Glimepiride Exporter Profile

Indian Pharmaceutical Exporter · #15 for Glimepiride · $508.7K export value · DGFT Verified

Intas Pharmaceuticals Limited is the #15 Indian exporter of Glimepiride with $508.7K in export value and 40 verified shipments. Intas Pharmaceuticals Limited holds a 0.7% market share in Glimepiride exports across 4 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Glimepiride Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Glimepiride export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Glimepiride?

Country	Value	Shipments	Share
MEXICO	$274.4K	22	53.9%
SOUTH AFRICA	$225.5K	15	44.3%
CONGO	$8.0K	2	1.6%
UNITED KINGDOM	$691	1	0.1%
ITALY	$677	1

Who Are the Top Buyers of Glimepiride from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
TO THE ORDER	MEXICO	$271.3K	21
ACCORD HEALTHCARE C/O UPD LEA GLEN	SOUTH AFRICA	$223.7K	14
UNION DE	CONGO	$8.0K	2
TO THE ORDER.	MEXICO	$3.1K	1
ACCORD HEALTHCARE C O UPD LEA GLEN	SOUTH AFRICA	$1.8K	1
ACCORD HEALTHCARE LTD	SPAIN	$705	2
ACCORD HEALTHCARE SLU	ITALY	$677	1
ACCORD HEALTHCARE B V	NETHERLANDS	$121	1

Intas Pharmaceuticals Limited supplies Glimepiride to 8 buyers globally. The largest buyer is TO THE ORDER (MEXICO), followed by ACCORD HEALTHCARE C/O UPD LEA GLEN (SOUTH AFRICA) and UNION DE (CONGO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Glimepiride Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARM DRUG&MED ADIRIPEM 4MG GLIMEPIRIDETABLETS 4MG EACH THEORETICAL WEIGHT OFTABLET CONT GLIMEPIRIDE 4MG (ASPERINV)	$148.9K	10
PHARMA DRUGS & MEDI ACCORD GLIMEPIRIDE 4	$139.8K	5
PHARMA DRUGS & MEDI ACCORD GLIMEPIRIDE 2	$37.8K	4
PHARMA DRUGS AND MEDI PHARMA DRUGS AND MEDI ADIRIPEM 4 MG GLIMEPIRIDE TABLETS 4MG AS PER INV	$34.1K	3
PHARM DRUG&MED:ADIRIPEM 2MG GLIMEPRIDE 2X15T(ACC-MEX) GLIMEPIRIDE TABLETS 2MG EACH THEORETICAL WEIGHT OF TABLE(ASPERINV)	$24.6K	2
PHARMA DRUGS AND MEDI ADIRIPEM 4 MG GLIMEPIRIDE TABLETS 4 MG AS PER INV	$21.9K	2
PHR DRUGS&MEDI ACCORD GLIMEPIRIDE 4 MG (	$16.6K	1
PHARM DRUG&MED ADIRIPEM 4 MG GLIMEPIRIDETABLETS 4 MG EACH THEORETICAL WEIGHT OFTABLET CONT GLIMEPIRIDE 4MG C(ASPERINV)	$15.0K	1
PHARMA DRUGS & MEDI ACCORD GLIMEPIRIDE 1	$12.1K	1
PH.DRU. & MED.: ACCORD GLIMEPIRIDE 4MG T	$11.5K	1

Intas Pharmaceuticals Limited exports 22 distinct Glimepiride formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARM DRUG&MED ADIRIPEM 4MG GLIMEPIRIDETABLETS 4MG EACH TH with 10 shipments worth $148.9K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Glimepiride Exporters?

Exporters ranked immediately above and below #15 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
13	ZENTIVA PRIVATE LIMITED	$693.1K	38	1	$18.2K
14	AZTEC PHARMA PRIVATE LIMITED	$607.9K	25	1	$24.3K
15	INTAS PHARMACEUTICALS LIMITED ★	$508.7K	40	4	$12.7K
12	DR REDDYS LABORATORIES LIMITED	$300.0K	6	1	$50.0K
7	FREDUN PHARMACEUTICALS LTD	$200.0K	4	1	$50.0K

Intas Pharmaceuticals Limited ranks #15 among 242 Indian Glimepiride exporters. Average shipment value of $12.7K compared to the market average of $96.6K. The closest competitors by value are ZENTIVA PRIVATE LIMITED and AZTEC PHARMA PRIVATE LIMITED.

Which Indian Ports Ship Glimepiride Exports?

Port	Shipments	% Share
SAHAR AIR	350	11.1%
NHAVA SHEVA SEA (INNSA1)	268	8.5%
SAHAR AIR CARGO ACC (INBOM4)	241	7.6%
DELHI AIR CARGO ACC (INDEL4)	228	7.2%
DELHI AIR	226	7.2%
JNPT/ NHAVA SHEVA SEA	172	5.4%
BANGALORE ACC (INBLR4)	148	4.7%
BANGALORE AIR	110	3.5%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Glimepiride Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Glimepiride shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 43 individual customs records matching Intas Pharmaceuticals Limited exporting Glimepiride, covering 22 formulations to 7 countries via 8 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 94+ countries, 535+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Glimepiride

Glimepiride

Intas Pharmaceuticals Limited — Glimepiride Exporter Profile

Intas Pharmaceuticals Limited — Glimepiride Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Glimepiride?

Who Are the Top Buyers of Glimepiride from Intas Pharmaceuticals Limited?

What Is India's Total Glimepiride Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Glimepiride Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Glimepiride Exporters?

What Glimepiride Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Glimepiride to Key Markets

Mexico — COFEPRIS

South Africa — SAHPRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Glimepiride Exporters?

Which Indian Ports Ship Glimepiride Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Glimepiride Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Glimepiride Export Data from Intas Pharmaceuticals Limited

Glimepiride Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source